Galy, led by CEO and Founder Luciano Bueno, develops cellular agriculture products beginning with GALY Cotton. Its core product, GALY Cotton, is a lab-grown cotton that the company says fully replicates traditional cotton in quality because it originates from an actual plant. Galy has developed a minimum-viable product and is working to enhance quality parameters and scale production from lab to pre-industrial scale. The company plans to expand its platform beyond cotton to other plant-cell products, targeting a global agricultural market valued in the article at $1.7 trillion annually. Galy highlights ESG benefits, customizable quality, and a roadmap to reach cost parity with conventional cotton. The company completed a $33M Series B to fund scaling and product development.

Total raised

$33M

Funding rounds

1

Latest round

Series B

Latest activity

Sep 2024